| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-06-25 |
4 |
AS |
$10.01 |
$94,865 |
D/D |
(9,473) |
168,380 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-01 |
4 |
AS |
$12.07 |
$128,665 |
D/D |
(10,000) |
300,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-02 |
4 |
AS |
$11.74 |
$117,381 |
D/D |
(10,000) |
290,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-04 |
4 |
AS |
$13.01 |
$130,108 |
D/D |
(10,000) |
280,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-05 |
4 |
AS |
$12.99 |
$129,875 |
D/D |
(10,000) |
270,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-13 |
4 |
AS |
$10.07 |
$100,714 |
D/D |
(10,000) |
260,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-14 |
4 |
AS |
$10.52 |
$105,200 |
D/D |
(10,000) |
250,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-12 |
4 |
AS |
$11.68 |
$116,842 |
D/D |
(10,000) |
240,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-13 |
4 |
AS |
$11.52 |
$115,169 |
D/D |
(10,000) |
230,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-31 |
4 |
D |
$12.60 |
$140,150 |
D/D |
(11,123) |
310,039 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-01-12 |
4 |
D |
$4.23 |
$55,180 |
D/D |
(13,045) |
206,638 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-08 |
4 |
OE |
$7.55 |
$100,000 |
D/D |
13,245 |
109,245 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2010-01-15 |
4 |
D |
$29.05 |
$425,757 |
D/D |
(14,656) |
463,177 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-03 |
4 |
AS |
$33.03 |
$627,505 |
D/D |
(19,000) |
289,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-03 |
4 |
OE |
$4.41 |
$86,975 |
D/D |
19,000 |
296,301 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-25 |
4 |
OE |
$4.90 |
$93,100 |
D/D |
19,000 |
308,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-25 |
4 |
AS |
$33.21 |
$630,908 |
D/D |
(19,000) |
289,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-25 |
4 |
OE |
$4.90 |
$93,100 |
D/D |
19,000 |
301,412 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-25 |
4 |
AS |
$40.71 |
$773,454 |
D/D |
(19,000) |
282,412 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-05-25 |
4 |
AS |
$40.00 |
$759,939 |
D/D |
(19,000) |
267,293 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-06-27 |
4 |
AS |
$38.69 |
$735,169 |
D/D |
(19,000) |
252,174 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-25 |
4 |
AS |
$38.37 |
$728,964 |
D/D |
(19,000) |
225,785 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
23,292 |
23,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
AS |
$20.22 |
$495,217 |
D/D |
(24,486) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
OE |
$0.45 |
$15,436 |
D/D |
24,486 |
24,486 |
0 |
- |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
